Live Breaking News & Updates on The 2023 San Antonio Breast Cancer Symposium

Stay updated with breaking news from The 2023 san antonio breast cancer symposium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sacibertinib Plus Endocrine Therapy Shows Early Safety, Activity in ER+/HER2+ Breast Cancer

Sacibertinib plus endocrine therapy demonstrated acceptable safety with early clinical activity in patients with estrogen receptor-positive/HER2-positive metastatic breast cancer. ....

San Antonio , United States , Huiping Li , University Cancer Hospital , Antonio Breast Cancer , Peking University Cancer Hospital , Neoadjuvant Her2 , Breast Cancer , Onclive Tv , The 2023 San Antonio Breast Cancer Symposium ,